...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!
AGORACOM NEWS FLASH
BREAKING: Amazon Web Services And Loop Insights Partner To Showcase Loop Venue Tracing Solution Via Joint Webcast To Global Audience
- Amazon Web Services and Loop Insights will be hosting an interactive webinar to showcase the Company ‘ s Venue Tracing Solution to a global audience on October 29th
- Will provide invitees with a first hand and interactive experience of Loop ‘ s End-To-End Venue Tracing Platform
- Will be an open invitation to all AWS and Loop partners from around the world from industries including but not limited to Airlines, Venue Owners, Sports & Entertainment, Telecom, and Government to learn about the technical, security, privacy, and commercial aspects of Loop ‘ s Venue Tracing Platform
Hub On AGORACOM / Read Release
Due Dilligence
GCFF Virtual Conference 9/10/2020 - Investing in Innovation
Posted by:
BearDownAZ
on
Sep 12, 2020 02:43PM
Epigenetic Therapeutic Targets Virtual Summit Presentation July 28, 2020
Posted by:
BearDownAZ
on
Jul 28, 2020 10:31PM
Resverlogix Corp. Links
GCFF Virtual Conference 9/10/2020 - Investing in Innovation
Posted by:
BearDownAZ
on
Sep 12, 2020 02:43PM
Epigenetic Therapeutic Targets Virtual Summit Presentation July 28, 2020
Posted by:
BearDownAZ
on
Jul 28, 2020 10:31PM
NEJM BETonMACE Editorial - Epigenetic Therapeutics for Cardiovascular Disease Writing, Erasing, Reading, and Maybe Forgetting
Posted by:
BearDownAZ
on
Mar 31, 2020 08:21AM
NEJM BETonMACE Publication - Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes A Randomized Clinical Trial
Posted by:
BearDownAZ
on
Mar 31, 2020 08:20AM
The BET Protein Inhibitor Apabetalone Reduces Congestive Heart Failure Incidence in Patients with Acute Coronary Syndrome and Diabetes: Results from the BETonMACE Trial - ACC/WCC 2020 Poster
Posted by:
BearDownAZ
on
Mar 31, 2020 08:18AM